Global Untargeted Metabolomics Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Untargeted Metabolomics market size was valued at US$ 1704 million in 2025 and is forecast to a readjusted size of US$ 3213 million by 2032 with a CAGR of 9.6% during review period.
Untargeted metabolomics is a study in which all detectable metabolites are identified and quantitated for analyzing the overall metabolic characteristics and discovering metabolic mechanisms behind the phenomenon. Also known as discovery metabolomics, untargeted metabolomics is a powerful tool for large-scale early phase diagnosis and discovery of new biomarkers. Compared to traditional metabolic quantitation methods, untargeted metabolomics is a high-throughput technology, enabling more comprehensive analysis with more accurate data acquisition, eliminating biased research direction.
This report is a detailed and comprehensive analysis for global Untargeted Metabolomics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Untargeted Metabolomics market size and forecasts, in consumption value ($ Million), 2021-2032
Global Untargeted Metabolomics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Untargeted Metabolomics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Untargeted Metabolomics market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Untargeted Metabolomics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Untargeted metabolomics is a study in which all detectable metabolites are identified and quantitated for analyzing the overall metabolic characteristics and discovering metabolic mechanisms behind the phenomenon. Also known as discovery metabolomics, untargeted metabolomics is a powerful tool for large-scale early phase diagnosis and discovery of new biomarkers. Compared to traditional metabolic quantitation methods, untargeted metabolomics is a high-throughput technology, enabling more comprehensive analysis with more accurate data acquisition, eliminating biased research direction.
This report is a detailed and comprehensive analysis for global Untargeted Metabolomics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Untargeted Metabolomics market size and forecasts, in consumption value ($ Million), 2021-2032
Global Untargeted Metabolomics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Untargeted Metabolomics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Untargeted Metabolomics market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Untargeted Metabolomics
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Untargeted Metabolomics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Plant Untargeted Metabolomics
- Human Untargeted Metabolomics
- Other
- Academic and Research Institutions
- Pharmaceutical and Biotechnology Companies
- Creative Dynamics Inc (Creative Proteomics)
- Metabolon
- Alfa Chemistry
- Novelgene Technologies
- MtoZ-Biolabs Inc.
- CD Genomics
- Metware Biotechnology Inc (Metware)
- BGI Genomics
- APPLIED PROTEIN TECHNOLOGY
- Suzhou PANOMIX Biomedical Tech Co.,Ltd
- OBiO Technology ( Shanghai ) Corp.,Ltd.
- Beijing Huayi innovation & BioTechnology Co., Ltd
- Abace Biotechnology
- Metabo-Profile
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
- Chapter 1, to describe Untargeted Metabolomics product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top players of Untargeted Metabolomics, with revenue, gross margin, and global market share of Untargeted Metabolomics from 2021 to 2026.
- Chapter 3, the Untargeted Metabolomics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
- Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Untargeted Metabolomics market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
- Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
- Chapter 12, the key raw materials and key suppliers, and industry chain of Untargeted Metabolomics.
- Chapter 13, to describe Untargeted Metabolomics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Untargeted Metabolomics by Type
1.3.1 Overview: Global Untargeted Metabolomics Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Untargeted Metabolomics Consumption Value Market Share by Type in 2025
1.3.3 Plant Untargeted Metabolomics
1.3.4 Human Untargeted Metabolomics
1.3.5 Other
1.4 Global Untargeted Metabolomics Market by Application
1.4.1 Overview: Global Untargeted Metabolomics Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Academic and Research Institutions
1.4.3 Pharmaceutical and Biotechnology Companies
1.5 Global Untargeted Metabolomics Market Size & Forecast
1.6 Global Untargeted Metabolomics Market Size and Forecast by Region
1.6.1 Global Untargeted Metabolomics Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Untargeted Metabolomics Market Size by Region, (2021-2032)
1.6.3 North America Untargeted Metabolomics Market Size and Prospect (2021-2032)
1.6.4 Europe Untargeted Metabolomics Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Untargeted Metabolomics Market Size and Prospect (2021-2032)
1.6.6 South America Untargeted Metabolomics Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Untargeted Metabolomics Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Creative Dynamics Inc (Creative Proteomics)
2.1.1 Creative Dynamics Inc (Creative Proteomics) Details
2.1.2 Creative Dynamics Inc (Creative Proteomics) Major Business
2.1.3 Creative Dynamics Inc (Creative Proteomics) Untargeted Metabolomics Product and Solutions
2.1.4 Creative Dynamics Inc (Creative Proteomics) Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Creative Dynamics Inc (Creative Proteomics) Recent Developments and Future Plans
2.2 Metabolon
2.2.1 Metabolon Details
2.2.2 Metabolon Major Business
2.2.3 Metabolon Untargeted Metabolomics Product and Solutions
2.2.4 Metabolon Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Metabolon Recent Developments and Future Plans
2.3 Alfa Chemistry
2.3.1 Alfa Chemistry Details
2.3.2 Alfa Chemistry Major Business
2.3.3 Alfa Chemistry Untargeted Metabolomics Product and Solutions
2.3.4 Alfa Chemistry Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Alfa Chemistry Recent Developments and Future Plans
2.4 Novelgene Technologies
2.4.1 Novelgene Technologies Details
2.4.2 Novelgene Technologies Major Business
2.4.3 Novelgene Technologies Untargeted Metabolomics Product and Solutions
2.4.4 Novelgene Technologies Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Novelgene Technologies Recent Developments and Future Plans
2.5 MtoZ-Biolabs Inc.
2.5.1 MtoZ-Biolabs Inc. Details
2.5.2 MtoZ-Biolabs Inc. Major Business
2.5.3 MtoZ-Biolabs Inc. Untargeted Metabolomics Product and Solutions
2.5.4 MtoZ-Biolabs Inc. Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 MtoZ-Biolabs Inc. Recent Developments and Future Plans
2.6 CD Genomics
2.6.1 CD Genomics Details
2.6.2 CD Genomics Major Business
2.6.3 CD Genomics Untargeted Metabolomics Product and Solutions
2.6.4 CD Genomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 CD Genomics Recent Developments and Future Plans
2.7 Metware Biotechnology Inc (Metware)
2.7.1 Metware Biotechnology Inc (Metware) Details
2.7.2 Metware Biotechnology Inc (Metware) Major Business
2.7.3 Metware Biotechnology Inc (Metware) Untargeted Metabolomics Product and Solutions
2.7.4 Metware Biotechnology Inc (Metware) Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Metware Biotechnology Inc (Metware) Recent Developments and Future Plans
2.8 BGI Genomics
2.8.1 BGI Genomics Details
2.8.2 BGI Genomics Major Business
2.8.3 BGI Genomics Untargeted Metabolomics Product and Solutions
2.8.4 BGI Genomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 BGI Genomics Recent Developments and Future Plans
2.9 APPLIED PROTEIN TECHNOLOGY
2.9.1 APPLIED PROTEIN TECHNOLOGY Details
2.9.2 APPLIED PROTEIN TECHNOLOGY Major Business
2.9.3 APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Product and Solutions
2.9.4 APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 APPLIED PROTEIN TECHNOLOGY Recent Developments and Future Plans
2.10 Suzhou PANOMIX Biomedical Tech Co.,Ltd
2.10.1 Suzhou PANOMIX Biomedical Tech Co.,Ltd Details
2.10.2 Suzhou PANOMIX Biomedical Tech Co.,Ltd Major Business
2.10.3 Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Product and Solutions
2.10.4 Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Suzhou PANOMIX Biomedical Tech Co.,Ltd Recent Developments and Future Plans
2.11 OBiO Technology ( Shanghai ) Corp.,Ltd.
2.11.1 OBiO Technology ( Shanghai ) Corp.,Ltd. Details
2.11.2 OBiO Technology ( Shanghai ) Corp.,Ltd. Major Business
2.11.3 OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Product and Solutions
2.11.4 OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Developments and Future Plans
2.12 Beijing Huayi innovation & BioTechnology Co., Ltd
2.12.1 Beijing Huayi innovation & BioTechnology Co., Ltd Details
2.12.2 Beijing Huayi innovation & BioTechnology Co., Ltd Major Business
2.12.3 Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Product and Solutions
2.12.4 Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Beijing Huayi innovation & BioTechnology Co., Ltd Recent Developments and Future Plans
2.13 Abace Biotechnology
2.13.1 Abace Biotechnology Details
2.13.2 Abace Biotechnology Major Business
2.13.3 Abace Biotechnology Untargeted Metabolomics Product and Solutions
2.13.4 Abace Biotechnology Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Abace Biotechnology Recent Developments and Future Plans
2.14 Metabo-Profile
2.14.1 Metabo-Profile Details
2.14.2 Metabo-Profile Major Business
2.14.3 Metabo-Profile Untargeted Metabolomics Product and Solutions
2.14.4 Metabo-Profile Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Metabo-Profile Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Untargeted Metabolomics Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Untargeted Metabolomics by Company Revenue
3.2.2 Top 3 Untargeted Metabolomics Players Market Share in 2025
3.2.3 Top 6 Untargeted Metabolomics Players Market Share in 2025
3.3 Untargeted Metabolomics Market: Overall Company Footprint Analysis
3.3.1 Untargeted Metabolomics Market: Region Footprint
3.3.2 Untargeted Metabolomics Market: Company Product Type Footprint
3.3.3 Untargeted Metabolomics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Untargeted Metabolomics Consumption Value and Market Share by Type (2021-2026)
4.2 Global Untargeted Metabolomics Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Untargeted Metabolomics Consumption Value Market Share by Application (2021-2026)
5.2 Global Untargeted Metabolomics Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Untargeted Metabolomics Consumption Value by Type (2021-2032)
6.2 North America Untargeted Metabolomics Market Size by Application (2021-2032)
6.3 North America Untargeted Metabolomics Market Size by Country
6.3.1 North America Untargeted Metabolomics Consumption Value by Country (2021-2032)
6.3.2 United States Untargeted Metabolomics Market Size and Forecast (2021-2032)
6.3.3 Canada Untargeted Metabolomics Market Size and Forecast (2021-2032)
6.3.4 Mexico Untargeted Metabolomics Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Untargeted Metabolomics Consumption Value by Type (2021-2032)
7.2 Europe Untargeted Metabolomics Consumption Value by Application (2021-2032)
7.3 Europe Untargeted Metabolomics Market Size by Country
7.3.1 Europe Untargeted Metabolomics Consumption Value by Country (2021-2032)
7.3.2 Germany Untargeted Metabolomics Market Size and Forecast (2021-2032)
7.3.3 France Untargeted Metabolomics Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Untargeted Metabolomics Market Size and Forecast (2021-2032)
7.3.5 Russia Untargeted Metabolomics Market Size and Forecast (2021-2032)
7.3.6 Italy Untargeted Metabolomics Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Untargeted Metabolomics Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Untargeted Metabolomics Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Untargeted Metabolomics Market Size by Region
8.3.1 Asia-Pacific Untargeted Metabolomics Consumption Value by Region (2021-2032)
8.3.2 China Untargeted Metabolomics Market Size and Forecast (2021-2032)
8.3.3 Japan Untargeted Metabolomics Market Size and Forecast (2021-2032)
8.3.4 South Korea Untargeted Metabolomics Market Size and Forecast (2021-2032)
8.3.5 India Untargeted Metabolomics Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Untargeted Metabolomics Market Size and Forecast (2021-2032)
8.3.7 Australia Untargeted Metabolomics Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Untargeted Metabolomics Consumption Value by Type (2021-2032)
9.2 South America Untargeted Metabolomics Consumption Value by Application (2021-2032)
9.3 South America Untargeted Metabolomics Market Size by Country
9.3.1 South America Untargeted Metabolomics Consumption Value by Country (2021-2032)
9.3.2 Brazil Untargeted Metabolomics Market Size and Forecast (2021-2032)
9.3.3 Argentina Untargeted Metabolomics Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Untargeted Metabolomics Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Untargeted Metabolomics Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Untargeted Metabolomics Market Size by Country
10.3.1 Middle East & Africa Untargeted Metabolomics Consumption Value by Country (2021-2032)
10.3.2 Turkey Untargeted Metabolomics Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Untargeted Metabolomics Market Size and Forecast (2021-2032)
10.3.4 UAE Untargeted Metabolomics Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Untargeted Metabolomics Market Drivers
11.2 Untargeted Metabolomics Market Restraints
11.3 Untargeted Metabolomics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Untargeted Metabolomics Industry Chain
12.2 Untargeted Metabolomics Upstream Analysis
12.3 Untargeted Metabolomics Midstream Analysis
12.4 Untargeted Metabolomics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Untargeted Metabolomics by Type
1.3.1 Overview: Global Untargeted Metabolomics Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Untargeted Metabolomics Consumption Value Market Share by Type in 2025
1.3.3 Plant Untargeted Metabolomics
1.3.4 Human Untargeted Metabolomics
1.3.5 Other
1.4 Global Untargeted Metabolomics Market by Application
1.4.1 Overview: Global Untargeted Metabolomics Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Academic and Research Institutions
1.4.3 Pharmaceutical and Biotechnology Companies
1.5 Global Untargeted Metabolomics Market Size & Forecast
1.6 Global Untargeted Metabolomics Market Size and Forecast by Region
1.6.1 Global Untargeted Metabolomics Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Untargeted Metabolomics Market Size by Region, (2021-2032)
1.6.3 North America Untargeted Metabolomics Market Size and Prospect (2021-2032)
1.6.4 Europe Untargeted Metabolomics Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Untargeted Metabolomics Market Size and Prospect (2021-2032)
1.6.6 South America Untargeted Metabolomics Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Untargeted Metabolomics Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Creative Dynamics Inc (Creative Proteomics)
2.1.1 Creative Dynamics Inc (Creative Proteomics) Details
2.1.2 Creative Dynamics Inc (Creative Proteomics) Major Business
2.1.3 Creative Dynamics Inc (Creative Proteomics) Untargeted Metabolomics Product and Solutions
2.1.4 Creative Dynamics Inc (Creative Proteomics) Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Creative Dynamics Inc (Creative Proteomics) Recent Developments and Future Plans
2.2 Metabolon
2.2.1 Metabolon Details
2.2.2 Metabolon Major Business
2.2.3 Metabolon Untargeted Metabolomics Product and Solutions
2.2.4 Metabolon Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Metabolon Recent Developments and Future Plans
2.3 Alfa Chemistry
2.3.1 Alfa Chemistry Details
2.3.2 Alfa Chemistry Major Business
2.3.3 Alfa Chemistry Untargeted Metabolomics Product and Solutions
2.3.4 Alfa Chemistry Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Alfa Chemistry Recent Developments and Future Plans
2.4 Novelgene Technologies
2.4.1 Novelgene Technologies Details
2.4.2 Novelgene Technologies Major Business
2.4.3 Novelgene Technologies Untargeted Metabolomics Product and Solutions
2.4.4 Novelgene Technologies Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Novelgene Technologies Recent Developments and Future Plans
2.5 MtoZ-Biolabs Inc.
2.5.1 MtoZ-Biolabs Inc. Details
2.5.2 MtoZ-Biolabs Inc. Major Business
2.5.3 MtoZ-Biolabs Inc. Untargeted Metabolomics Product and Solutions
2.5.4 MtoZ-Biolabs Inc. Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 MtoZ-Biolabs Inc. Recent Developments and Future Plans
2.6 CD Genomics
2.6.1 CD Genomics Details
2.6.2 CD Genomics Major Business
2.6.3 CD Genomics Untargeted Metabolomics Product and Solutions
2.6.4 CD Genomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 CD Genomics Recent Developments and Future Plans
2.7 Metware Biotechnology Inc (Metware)
2.7.1 Metware Biotechnology Inc (Metware) Details
2.7.2 Metware Biotechnology Inc (Metware) Major Business
2.7.3 Metware Biotechnology Inc (Metware) Untargeted Metabolomics Product and Solutions
2.7.4 Metware Biotechnology Inc (Metware) Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Metware Biotechnology Inc (Metware) Recent Developments and Future Plans
2.8 BGI Genomics
2.8.1 BGI Genomics Details
2.8.2 BGI Genomics Major Business
2.8.3 BGI Genomics Untargeted Metabolomics Product and Solutions
2.8.4 BGI Genomics Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 BGI Genomics Recent Developments and Future Plans
2.9 APPLIED PROTEIN TECHNOLOGY
2.9.1 APPLIED PROTEIN TECHNOLOGY Details
2.9.2 APPLIED PROTEIN TECHNOLOGY Major Business
2.9.3 APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Product and Solutions
2.9.4 APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 APPLIED PROTEIN TECHNOLOGY Recent Developments and Future Plans
2.10 Suzhou PANOMIX Biomedical Tech Co.,Ltd
2.10.1 Suzhou PANOMIX Biomedical Tech Co.,Ltd Details
2.10.2 Suzhou PANOMIX Biomedical Tech Co.,Ltd Major Business
2.10.3 Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Product and Solutions
2.10.4 Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Suzhou PANOMIX Biomedical Tech Co.,Ltd Recent Developments and Future Plans
2.11 OBiO Technology ( Shanghai ) Corp.,Ltd.
2.11.1 OBiO Technology ( Shanghai ) Corp.,Ltd. Details
2.11.2 OBiO Technology ( Shanghai ) Corp.,Ltd. Major Business
2.11.3 OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Product and Solutions
2.11.4 OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Developments and Future Plans
2.12 Beijing Huayi innovation & BioTechnology Co., Ltd
2.12.1 Beijing Huayi innovation & BioTechnology Co., Ltd Details
2.12.2 Beijing Huayi innovation & BioTechnology Co., Ltd Major Business
2.12.3 Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Product and Solutions
2.12.4 Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Beijing Huayi innovation & BioTechnology Co., Ltd Recent Developments and Future Plans
2.13 Abace Biotechnology
2.13.1 Abace Biotechnology Details
2.13.2 Abace Biotechnology Major Business
2.13.3 Abace Biotechnology Untargeted Metabolomics Product and Solutions
2.13.4 Abace Biotechnology Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Abace Biotechnology Recent Developments and Future Plans
2.14 Metabo-Profile
2.14.1 Metabo-Profile Details
2.14.2 Metabo-Profile Major Business
2.14.3 Metabo-Profile Untargeted Metabolomics Product and Solutions
2.14.4 Metabo-Profile Untargeted Metabolomics Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Metabo-Profile Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Untargeted Metabolomics Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Untargeted Metabolomics by Company Revenue
3.2.2 Top 3 Untargeted Metabolomics Players Market Share in 2025
3.2.3 Top 6 Untargeted Metabolomics Players Market Share in 2025
3.3 Untargeted Metabolomics Market: Overall Company Footprint Analysis
3.3.1 Untargeted Metabolomics Market: Region Footprint
3.3.2 Untargeted Metabolomics Market: Company Product Type Footprint
3.3.3 Untargeted Metabolomics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Untargeted Metabolomics Consumption Value and Market Share by Type (2021-2026)
4.2 Global Untargeted Metabolomics Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Untargeted Metabolomics Consumption Value Market Share by Application (2021-2026)
5.2 Global Untargeted Metabolomics Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Untargeted Metabolomics Consumption Value by Type (2021-2032)
6.2 North America Untargeted Metabolomics Market Size by Application (2021-2032)
6.3 North America Untargeted Metabolomics Market Size by Country
6.3.1 North America Untargeted Metabolomics Consumption Value by Country (2021-2032)
6.3.2 United States Untargeted Metabolomics Market Size and Forecast (2021-2032)
6.3.3 Canada Untargeted Metabolomics Market Size and Forecast (2021-2032)
6.3.4 Mexico Untargeted Metabolomics Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Untargeted Metabolomics Consumption Value by Type (2021-2032)
7.2 Europe Untargeted Metabolomics Consumption Value by Application (2021-2032)
7.3 Europe Untargeted Metabolomics Market Size by Country
7.3.1 Europe Untargeted Metabolomics Consumption Value by Country (2021-2032)
7.3.2 Germany Untargeted Metabolomics Market Size and Forecast (2021-2032)
7.3.3 France Untargeted Metabolomics Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Untargeted Metabolomics Market Size and Forecast (2021-2032)
7.3.5 Russia Untargeted Metabolomics Market Size and Forecast (2021-2032)
7.3.6 Italy Untargeted Metabolomics Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Untargeted Metabolomics Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Untargeted Metabolomics Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Untargeted Metabolomics Market Size by Region
8.3.1 Asia-Pacific Untargeted Metabolomics Consumption Value by Region (2021-2032)
8.3.2 China Untargeted Metabolomics Market Size and Forecast (2021-2032)
8.3.3 Japan Untargeted Metabolomics Market Size and Forecast (2021-2032)
8.3.4 South Korea Untargeted Metabolomics Market Size and Forecast (2021-2032)
8.3.5 India Untargeted Metabolomics Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Untargeted Metabolomics Market Size and Forecast (2021-2032)
8.3.7 Australia Untargeted Metabolomics Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Untargeted Metabolomics Consumption Value by Type (2021-2032)
9.2 South America Untargeted Metabolomics Consumption Value by Application (2021-2032)
9.3 South America Untargeted Metabolomics Market Size by Country
9.3.1 South America Untargeted Metabolomics Consumption Value by Country (2021-2032)
9.3.2 Brazil Untargeted Metabolomics Market Size and Forecast (2021-2032)
9.3.3 Argentina Untargeted Metabolomics Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Untargeted Metabolomics Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Untargeted Metabolomics Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Untargeted Metabolomics Market Size by Country
10.3.1 Middle East & Africa Untargeted Metabolomics Consumption Value by Country (2021-2032)
10.3.2 Turkey Untargeted Metabolomics Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Untargeted Metabolomics Market Size and Forecast (2021-2032)
10.3.4 UAE Untargeted Metabolomics Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Untargeted Metabolomics Market Drivers
11.2 Untargeted Metabolomics Market Restraints
11.3 Untargeted Metabolomics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Untargeted Metabolomics Industry Chain
12.2 Untargeted Metabolomics Upstream Analysis
12.3 Untargeted Metabolomics Midstream Analysis
12.4 Untargeted Metabolomics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Untargeted Metabolomics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Untargeted Metabolomics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Untargeted Metabolomics Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Untargeted Metabolomics Consumption Value by Region (2027-2032) & (USD Million)
Table 5. Creative Dynamics Inc (Creative Proteomics) Company Information, Head Office, and Major Competitors
Table 6. Creative Dynamics Inc (Creative Proteomics) Major Business
Table 7. Creative Dynamics Inc (Creative Proteomics) Untargeted Metabolomics Product and Solutions
Table 8. Creative Dynamics Inc (Creative Proteomics) Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Creative Dynamics Inc (Creative Proteomics) Recent Developments and Future Plans
Table 10. Metabolon Company Information, Head Office, and Major Competitors
Table 11. Metabolon Major Business
Table 12. Metabolon Untargeted Metabolomics Product and Solutions
Table 13. Metabolon Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Metabolon Recent Developments and Future Plans
Table 15. Alfa Chemistry Company Information, Head Office, and Major Competitors
Table 16. Alfa Chemistry Major Business
Table 17. Alfa Chemistry Untargeted Metabolomics Product and Solutions
Table 18. Alfa Chemistry Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Novelgene Technologies Company Information, Head Office, and Major Competitors
Table 20. Novelgene Technologies Major Business
Table 21. Novelgene Technologies Untargeted Metabolomics Product and Solutions
Table 22. Novelgene Technologies Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Novelgene Technologies Recent Developments and Future Plans
Table 24. MtoZ-Biolabs Inc. Company Information, Head Office, and Major Competitors
Table 25. MtoZ-Biolabs Inc. Major Business
Table 26. MtoZ-Biolabs Inc. Untargeted Metabolomics Product and Solutions
Table 27. MtoZ-Biolabs Inc. Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. MtoZ-Biolabs Inc. Recent Developments and Future Plans
Table 29. CD Genomics Company Information, Head Office, and Major Competitors
Table 30. CD Genomics Major Business
Table 31. CD Genomics Untargeted Metabolomics Product and Solutions
Table 32. CD Genomics Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. CD Genomics Recent Developments and Future Plans
Table 34. Metware Biotechnology Inc (Metware) Company Information, Head Office, and Major Competitors
Table 35. Metware Biotechnology Inc (Metware) Major Business
Table 36. Metware Biotechnology Inc (Metware) Untargeted Metabolomics Product and Solutions
Table 37. Metware Biotechnology Inc (Metware) Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Metware Biotechnology Inc (Metware) Recent Developments and Future Plans
Table 39. BGI Genomics Company Information, Head Office, and Major Competitors
Table 40. BGI Genomics Major Business
Table 41. BGI Genomics Untargeted Metabolomics Product and Solutions
Table 42. BGI Genomics Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. BGI Genomics Recent Developments and Future Plans
Table 44. APPLIED PROTEIN TECHNOLOGY Company Information, Head Office, and Major Competitors
Table 45. APPLIED PROTEIN TECHNOLOGY Major Business
Table 46. APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Product and Solutions
Table 47. APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. APPLIED PROTEIN TECHNOLOGY Recent Developments and Future Plans
Table 49. Suzhou PANOMIX Biomedical Tech Co.,Ltd Company Information, Head Office, and Major Competitors
Table 50. Suzhou PANOMIX Biomedical Tech Co.,Ltd Major Business
Table 51. Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Product and Solutions
Table 52. Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Suzhou PANOMIX Biomedical Tech Co.,Ltd Recent Developments and Future Plans
Table 54. OBiO Technology ( Shanghai ) Corp.,Ltd. Company Information, Head Office, and Major Competitors
Table 55. OBiO Technology ( Shanghai ) Corp.,Ltd. Major Business
Table 56. OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Product and Solutions
Table 57. OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Developments and Future Plans
Table 59. Beijing Huayi innovation & BioTechnology Co., Ltd Company Information, Head Office, and Major Competitors
Table 60. Beijing Huayi innovation & BioTechnology Co., Ltd Major Business
Table 61. Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Product and Solutions
Table 62. Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. Beijing Huayi innovation & BioTechnology Co., Ltd Recent Developments and Future Plans
Table 64. Abace Biotechnology Company Information, Head Office, and Major Competitors
Table 65. Abace Biotechnology Major Business
Table 66. Abace Biotechnology Untargeted Metabolomics Product and Solutions
Table 67. Abace Biotechnology Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. Abace Biotechnology Recent Developments and Future Plans
Table 69. Metabo-Profile Company Information, Head Office, and Major Competitors
Table 70. Metabo-Profile Major Business
Table 71. Metabo-Profile Untargeted Metabolomics Product and Solutions
Table 72. Metabo-Profile Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 73. Metabo-Profile Recent Developments and Future Plans
Table 74. Global Untargeted Metabolomics Revenue (USD Million) by Players (2021-2026)
Table 75. Global Untargeted Metabolomics Revenue Share by Players (2021-2026)
Table 76. Breakdown of Untargeted Metabolomics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 77. Market Position of Players in Untargeted Metabolomics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 78. Head Office of Key Untargeted Metabolomics Players
Table 79. Untargeted Metabolomics Market: Company Product Type Footprint
Table 80. Untargeted Metabolomics Market: Company Product Application Footprint
Table 81. Untargeted Metabolomics New Market Entrants and Barriers to Market Entry
Table 82. Untargeted Metabolomics Mergers, Acquisition, Agreements, and Collaborations
Table 83. Global Untargeted Metabolomics Consumption Value (USD Million) by Type (2021-2026)
Table 84. Global Untargeted Metabolomics Consumption Value Share by Type (2021-2026)
Table 85. Global Untargeted Metabolomics Consumption Value Forecast by Type (2027-2032)
Table 86. Global Untargeted Metabolomics Consumption Value by Application (2021-2026)
Table 87. Global Untargeted Metabolomics Consumption Value Forecast by Application (2027-2032)
Table 88. North America Untargeted Metabolomics Consumption Value by Type (2021-2026) & (USD Million)
Table 89. North America Untargeted Metabolomics Consumption Value by Type (2027-2032) & (USD Million)
Table 90. North America Untargeted Metabolomics Consumption Value by Application (2021-2026) & (USD Million)
Table 91. North America Untargeted Metabolomics Consumption Value by Application (2027-2032) & (USD Million)
Table 92. North America Untargeted Metabolomics Consumption Value by Country (2021-2026) & (USD Million)
Table 93. North America Untargeted Metabolomics Consumption Value by Country (2027-2032) & (USD Million)
Table 94. Europe Untargeted Metabolomics Consumption Value by Type (2021-2026) & (USD Million)
Table 95. Europe Untargeted Metabolomics Consumption Value by Type (2027-2032) & (USD Million)
Table 96. Europe Untargeted Metabolomics Consumption Value by Application (2021-2026) & (USD Million)
Table 97. Europe Untargeted Metabolomics Consumption Value by Application (2027-2032) & (USD Million)
Table 98. Europe Untargeted Metabolomics Consumption Value by Country (2021-2026) & (USD Million)
Table 99. Europe Untargeted Metabolomics Consumption Value by Country (2027-2032) & (USD Million)
Table 100. Asia-Pacific Untargeted Metabolomics Consumption Value by Type (2021-2026) & (USD Million)
Table 101. Asia-Pacific Untargeted Metabolomics Consumption Value by Type (2027-2032) & (USD Million)
Table 102. Asia-Pacific Untargeted Metabolomics Consumption Value by Application (2021-2026) & (USD Million)
Table 103. Asia-Pacific Untargeted Metabolomics Consumption Value by Application (2027-2032) & (USD Million)
Table 104. Asia-Pacific Untargeted Metabolomics Consumption Value by Region (2021-2026) & (USD Million)
Table 105. Asia-Pacific Untargeted Metabolomics Consumption Value by Region (2027-2032) & (USD Million)
Table 106. South America Untargeted Metabolomics Consumption Value by Type (2021-2026) & (USD Million)
Table 107. South America Untargeted Metabolomics Consumption Value by Type (2027-2032) & (USD Million)
Table 108. South America Untargeted Metabolomics Consumption Value by Application (2021-2026) & (USD Million)
Table 109. South America Untargeted Metabolomics Consumption Value by Application (2027-2032) & (USD Million)
Table 110. South America Untargeted Metabolomics Consumption Value by Country (2021-2026) & (USD Million)
Table 111. South America Untargeted Metabolomics Consumption Value by Country (2027-2032) & (USD Million)
Table 112. Middle East & Africa Untargeted Metabolomics Consumption Value by Type (2021-2026) & (USD Million)
Table 113. Middle East & Africa Untargeted Metabolomics Consumption Value by Type (2027-2032) & (USD Million)
Table 114. Middle East & Africa Untargeted Metabolomics Consumption Value by Application (2021-2026) & (USD Million)
Table 115. Middle East & Africa Untargeted Metabolomics Consumption Value by Application (2027-2032) & (USD Million)
Table 116. Middle East & Africa Untargeted Metabolomics Consumption Value by Country (2021-2026) & (USD Million)
Table 117. Middle East & Africa Untargeted Metabolomics Consumption Value by Country (2027-2032) & (USD Million)
Table 118. Global Key Players of Untargeted Metabolomics Upstream (Raw Materials)
Table 119. Global Untargeted Metabolomics Typical Customers
Table 1. Global Untargeted Metabolomics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Untargeted Metabolomics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Untargeted Metabolomics Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Untargeted Metabolomics Consumption Value by Region (2027-2032) & (USD Million)
Table 5. Creative Dynamics Inc (Creative Proteomics) Company Information, Head Office, and Major Competitors
Table 6. Creative Dynamics Inc (Creative Proteomics) Major Business
Table 7. Creative Dynamics Inc (Creative Proteomics) Untargeted Metabolomics Product and Solutions
Table 8. Creative Dynamics Inc (Creative Proteomics) Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Creative Dynamics Inc (Creative Proteomics) Recent Developments and Future Plans
Table 10. Metabolon Company Information, Head Office, and Major Competitors
Table 11. Metabolon Major Business
Table 12. Metabolon Untargeted Metabolomics Product and Solutions
Table 13. Metabolon Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Metabolon Recent Developments and Future Plans
Table 15. Alfa Chemistry Company Information, Head Office, and Major Competitors
Table 16. Alfa Chemistry Major Business
Table 17. Alfa Chemistry Untargeted Metabolomics Product and Solutions
Table 18. Alfa Chemistry Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Novelgene Technologies Company Information, Head Office, and Major Competitors
Table 20. Novelgene Technologies Major Business
Table 21. Novelgene Technologies Untargeted Metabolomics Product and Solutions
Table 22. Novelgene Technologies Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Novelgene Technologies Recent Developments and Future Plans
Table 24. MtoZ-Biolabs Inc. Company Information, Head Office, and Major Competitors
Table 25. MtoZ-Biolabs Inc. Major Business
Table 26. MtoZ-Biolabs Inc. Untargeted Metabolomics Product and Solutions
Table 27. MtoZ-Biolabs Inc. Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. MtoZ-Biolabs Inc. Recent Developments and Future Plans
Table 29. CD Genomics Company Information, Head Office, and Major Competitors
Table 30. CD Genomics Major Business
Table 31. CD Genomics Untargeted Metabolomics Product and Solutions
Table 32. CD Genomics Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. CD Genomics Recent Developments and Future Plans
Table 34. Metware Biotechnology Inc (Metware) Company Information, Head Office, and Major Competitors
Table 35. Metware Biotechnology Inc (Metware) Major Business
Table 36. Metware Biotechnology Inc (Metware) Untargeted Metabolomics Product and Solutions
Table 37. Metware Biotechnology Inc (Metware) Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Metware Biotechnology Inc (Metware) Recent Developments and Future Plans
Table 39. BGI Genomics Company Information, Head Office, and Major Competitors
Table 40. BGI Genomics Major Business
Table 41. BGI Genomics Untargeted Metabolomics Product and Solutions
Table 42. BGI Genomics Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. BGI Genomics Recent Developments and Future Plans
Table 44. APPLIED PROTEIN TECHNOLOGY Company Information, Head Office, and Major Competitors
Table 45. APPLIED PROTEIN TECHNOLOGY Major Business
Table 46. APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Product and Solutions
Table 47. APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. APPLIED PROTEIN TECHNOLOGY Recent Developments and Future Plans
Table 49. Suzhou PANOMIX Biomedical Tech Co.,Ltd Company Information, Head Office, and Major Competitors
Table 50. Suzhou PANOMIX Biomedical Tech Co.,Ltd Major Business
Table 51. Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Product and Solutions
Table 52. Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Suzhou PANOMIX Biomedical Tech Co.,Ltd Recent Developments and Future Plans
Table 54. OBiO Technology ( Shanghai ) Corp.,Ltd. Company Information, Head Office, and Major Competitors
Table 55. OBiO Technology ( Shanghai ) Corp.,Ltd. Major Business
Table 56. OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Product and Solutions
Table 57. OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Developments and Future Plans
Table 59. Beijing Huayi innovation & BioTechnology Co., Ltd Company Information, Head Office, and Major Competitors
Table 60. Beijing Huayi innovation & BioTechnology Co., Ltd Major Business
Table 61. Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Product and Solutions
Table 62. Beijing Huayi innovation & BioTechnology Co., Ltd Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. Beijing Huayi innovation & BioTechnology Co., Ltd Recent Developments and Future Plans
Table 64. Abace Biotechnology Company Information, Head Office, and Major Competitors
Table 65. Abace Biotechnology Major Business
Table 66. Abace Biotechnology Untargeted Metabolomics Product and Solutions
Table 67. Abace Biotechnology Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. Abace Biotechnology Recent Developments and Future Plans
Table 69. Metabo-Profile Company Information, Head Office, and Major Competitors
Table 70. Metabo-Profile Major Business
Table 71. Metabo-Profile Untargeted Metabolomics Product and Solutions
Table 72. Metabo-Profile Untargeted Metabolomics Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 73. Metabo-Profile Recent Developments and Future Plans
Table 74. Global Untargeted Metabolomics Revenue (USD Million) by Players (2021-2026)
Table 75. Global Untargeted Metabolomics Revenue Share by Players (2021-2026)
Table 76. Breakdown of Untargeted Metabolomics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 77. Market Position of Players in Untargeted Metabolomics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 78. Head Office of Key Untargeted Metabolomics Players
Table 79. Untargeted Metabolomics Market: Company Product Type Footprint
Table 80. Untargeted Metabolomics Market: Company Product Application Footprint
Table 81. Untargeted Metabolomics New Market Entrants and Barriers to Market Entry
Table 82. Untargeted Metabolomics Mergers, Acquisition, Agreements, and Collaborations
Table 83. Global Untargeted Metabolomics Consumption Value (USD Million) by Type (2021-2026)
Table 84. Global Untargeted Metabolomics Consumption Value Share by Type (2021-2026)
Table 85. Global Untargeted Metabolomics Consumption Value Forecast by Type (2027-2032)
Table 86. Global Untargeted Metabolomics Consumption Value by Application (2021-2026)
Table 87. Global Untargeted Metabolomics Consumption Value Forecast by Application (2027-2032)
Table 88. North America Untargeted Metabolomics Consumption Value by Type (2021-2026) & (USD Million)
Table 89. North America Untargeted Metabolomics Consumption Value by Type (2027-2032) & (USD Million)
Table 90. North America Untargeted Metabolomics Consumption Value by Application (2021-2026) & (USD Million)
Table 91. North America Untargeted Metabolomics Consumption Value by Application (2027-2032) & (USD Million)
Table 92. North America Untargeted Metabolomics Consumption Value by Country (2021-2026) & (USD Million)
Table 93. North America Untargeted Metabolomics Consumption Value by Country (2027-2032) & (USD Million)
Table 94. Europe Untargeted Metabolomics Consumption Value by Type (2021-2026) & (USD Million)
Table 95. Europe Untargeted Metabolomics Consumption Value by Type (2027-2032) & (USD Million)
Table 96. Europe Untargeted Metabolomics Consumption Value by Application (2021-2026) & (USD Million)
Table 97. Europe Untargeted Metabolomics Consumption Value by Application (2027-2032) & (USD Million)
Table 98. Europe Untargeted Metabolomics Consumption Value by Country (2021-2026) & (USD Million)
Table 99. Europe Untargeted Metabolomics Consumption Value by Country (2027-2032) & (USD Million)
Table 100. Asia-Pacific Untargeted Metabolomics Consumption Value by Type (2021-2026) & (USD Million)
Table 101. Asia-Pacific Untargeted Metabolomics Consumption Value by Type (2027-2032) & (USD Million)
Table 102. Asia-Pacific Untargeted Metabolomics Consumption Value by Application (2021-2026) & (USD Million)
Table 103. Asia-Pacific Untargeted Metabolomics Consumption Value by Application (2027-2032) & (USD Million)
Table 104. Asia-Pacific Untargeted Metabolomics Consumption Value by Region (2021-2026) & (USD Million)
Table 105. Asia-Pacific Untargeted Metabolomics Consumption Value by Region (2027-2032) & (USD Million)
Table 106. South America Untargeted Metabolomics Consumption Value by Type (2021-2026) & (USD Million)
Table 107. South America Untargeted Metabolomics Consumption Value by Type (2027-2032) & (USD Million)
Table 108. South America Untargeted Metabolomics Consumption Value by Application (2021-2026) & (USD Million)
Table 109. South America Untargeted Metabolomics Consumption Value by Application (2027-2032) & (USD Million)
Table 110. South America Untargeted Metabolomics Consumption Value by Country (2021-2026) & (USD Million)
Table 111. South America Untargeted Metabolomics Consumption Value by Country (2027-2032) & (USD Million)
Table 112. Middle East & Africa Untargeted Metabolomics Consumption Value by Type (2021-2026) & (USD Million)
Table 113. Middle East & Africa Untargeted Metabolomics Consumption Value by Type (2027-2032) & (USD Million)
Table 114. Middle East & Africa Untargeted Metabolomics Consumption Value by Application (2021-2026) & (USD Million)
Table 115. Middle East & Africa Untargeted Metabolomics Consumption Value by Application (2027-2032) & (USD Million)
Table 116. Middle East & Africa Untargeted Metabolomics Consumption Value by Country (2021-2026) & (USD Million)
Table 117. Middle East & Africa Untargeted Metabolomics Consumption Value by Country (2027-2032) & (USD Million)
Table 118. Global Key Players of Untargeted Metabolomics Upstream (Raw Materials)
Table 119. Global Untargeted Metabolomics Typical Customers
LIST OF FIGURES
Figure 1. Untargeted Metabolomics Picture
Figure 2. Global Untargeted Metabolomics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Untargeted Metabolomics Consumption Value Market Share by Type in 2025
Figure 4. Plant Untargeted Metabolomics
Figure 5. Human Untargeted Metabolomics
Figure 6. Other
Figure 7. Global Untargeted Metabolomics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 8. Untargeted Metabolomics Consumption Value Market Share by Application in 2025
Figure 9. Academic and Research Institutions Picture
Figure 10. Pharmaceutical and Biotechnology Companies Picture
Figure 11. Global Untargeted Metabolomics Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global Untargeted Metabolomics Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global Market Untargeted Metabolomics Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 14. Global Untargeted Metabolomics Consumption Value Market Share by Region (2021-2032)
Figure 15. Global Untargeted Metabolomics Consumption Value Market Share by Region in 2025
Figure 16. North America Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 17. Europe Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 18. Asia-Pacific Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 19. South America Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 20. Middle East & Africa Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global Untargeted Metabolomics Revenue Share by Players in 2025
Figure 23. Untargeted Metabolomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 24. Market Share of Untargeted Metabolomics by Player Revenue in 2025
Figure 25. Top 3 Untargeted Metabolomics Players Market Share in 2025
Figure 26. Top 6 Untargeted Metabolomics Players Market Share in 2025
Figure 27. Global Untargeted Metabolomics Consumption Value Share by Type (2021-2026)
Figure 28. Global Untargeted Metabolomics Market Share Forecast by Type (2027-2032)
Figure 29. Global Untargeted Metabolomics Consumption Value Share by Application (2021-2026)
Figure 30. Global Untargeted Metabolomics Market Share Forecast by Application (2027-2032)
Figure 31. North America Untargeted Metabolomics Consumption Value Market Share by Type (2021-2032)
Figure 32. North America Untargeted Metabolomics Consumption Value Market Share by Application (2021-2032)
Figure 33. North America Untargeted Metabolomics Consumption Value Market Share by Country (2021-2032)
Figure 34. United States Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 35. Canada Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 36. Mexico Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 37. Europe Untargeted Metabolomics Consumption Value Market Share by Type (2021-2032)
Figure 38. Europe Untargeted Metabolomics Consumption Value Market Share by Application (2021-2032)
Figure 39. Europe Untargeted Metabolomics Consumption Value Market Share by Country (2021-2032)
Figure 40. Germany Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 41. France Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 42. United Kingdom Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 43. Russia Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 44. Italy Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 45. Asia-Pacific Untargeted Metabolomics Consumption Value Market Share by Type (2021-2032)
Figure 46. Asia-Pacific Untargeted Metabolomics Consumption Value Market Share by Application (2021-2032)
Figure 47. Asia-Pacific Untargeted Metabolomics Consumption Value Market Share by Region (2021-2032)
Figure 48. China Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 49. Japan Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 50. South Korea Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 51. India Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 52. Southeast Asia Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 53. Australia Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 54. South America Untargeted Metabolomics Consumption Value Market Share by Type (2021-2032)
Figure 55. South America Untargeted Metabolomics Consumption Value Market Share by Application (2021-2032)
Figure 56. South America Untargeted Metabolomics Consumption Value Market Share by Country (2021-2032)
Figure 57. Brazil Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 58. Argentina Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 59. Middle East & Africa Untargeted Metabolomics Consumption Value Market Share by Type (2021-2032)
Figure 60. Middle East & Africa Untargeted Metabolomics Consumption Value Market Share by Application (2021-2032)
Figure 61. Middle East & Africa Untargeted Metabolomics Consumption Value Market Share by Country (2021-2032)
Figure 62. Turkey Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 63. Saudi Arabia Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 64. UAE Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 65. Untargeted Metabolomics Market Drivers
Figure 66. Untargeted Metabolomics Market Restraints
Figure 67. Untargeted Metabolomics Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Untargeted Metabolomics Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Untargeted Metabolomics Picture
Figure 2. Global Untargeted Metabolomics Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Untargeted Metabolomics Consumption Value Market Share by Type in 2025
Figure 4. Plant Untargeted Metabolomics
Figure 5. Human Untargeted Metabolomics
Figure 6. Other
Figure 7. Global Untargeted Metabolomics Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 8. Untargeted Metabolomics Consumption Value Market Share by Application in 2025
Figure 9. Academic and Research Institutions Picture
Figure 10. Pharmaceutical and Biotechnology Companies Picture
Figure 11. Global Untargeted Metabolomics Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global Untargeted Metabolomics Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global Market Untargeted Metabolomics Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 14. Global Untargeted Metabolomics Consumption Value Market Share by Region (2021-2032)
Figure 15. Global Untargeted Metabolomics Consumption Value Market Share by Region in 2025
Figure 16. North America Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 17. Europe Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 18. Asia-Pacific Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 19. South America Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 20. Middle East & Africa Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global Untargeted Metabolomics Revenue Share by Players in 2025
Figure 23. Untargeted Metabolomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 24. Market Share of Untargeted Metabolomics by Player Revenue in 2025
Figure 25. Top 3 Untargeted Metabolomics Players Market Share in 2025
Figure 26. Top 6 Untargeted Metabolomics Players Market Share in 2025
Figure 27. Global Untargeted Metabolomics Consumption Value Share by Type (2021-2026)
Figure 28. Global Untargeted Metabolomics Market Share Forecast by Type (2027-2032)
Figure 29. Global Untargeted Metabolomics Consumption Value Share by Application (2021-2026)
Figure 30. Global Untargeted Metabolomics Market Share Forecast by Application (2027-2032)
Figure 31. North America Untargeted Metabolomics Consumption Value Market Share by Type (2021-2032)
Figure 32. North America Untargeted Metabolomics Consumption Value Market Share by Application (2021-2032)
Figure 33. North America Untargeted Metabolomics Consumption Value Market Share by Country (2021-2032)
Figure 34. United States Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 35. Canada Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 36. Mexico Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 37. Europe Untargeted Metabolomics Consumption Value Market Share by Type (2021-2032)
Figure 38. Europe Untargeted Metabolomics Consumption Value Market Share by Application (2021-2032)
Figure 39. Europe Untargeted Metabolomics Consumption Value Market Share by Country (2021-2032)
Figure 40. Germany Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 41. France Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 42. United Kingdom Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 43. Russia Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 44. Italy Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 45. Asia-Pacific Untargeted Metabolomics Consumption Value Market Share by Type (2021-2032)
Figure 46. Asia-Pacific Untargeted Metabolomics Consumption Value Market Share by Application (2021-2032)
Figure 47. Asia-Pacific Untargeted Metabolomics Consumption Value Market Share by Region (2021-2032)
Figure 48. China Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 49. Japan Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 50. South Korea Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 51. India Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 52. Southeast Asia Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 53. Australia Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 54. South America Untargeted Metabolomics Consumption Value Market Share by Type (2021-2032)
Figure 55. South America Untargeted Metabolomics Consumption Value Market Share by Application (2021-2032)
Figure 56. South America Untargeted Metabolomics Consumption Value Market Share by Country (2021-2032)
Figure 57. Brazil Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 58. Argentina Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 59. Middle East & Africa Untargeted Metabolomics Consumption Value Market Share by Type (2021-2032)
Figure 60. Middle East & Africa Untargeted Metabolomics Consumption Value Market Share by Application (2021-2032)
Figure 61. Middle East & Africa Untargeted Metabolomics Consumption Value Market Share by Country (2021-2032)
Figure 62. Turkey Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 63. Saudi Arabia Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 64. UAE Untargeted Metabolomics Consumption Value (2021-2032) & (USD Million)
Figure 65. Untargeted Metabolomics Market Drivers
Figure 66. Untargeted Metabolomics Market Restraints
Figure 67. Untargeted Metabolomics Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Untargeted Metabolomics Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
